...Paul Abrams Objectives: Urodynamic investigations provide an objective, quantitative evaluation of urinary function in patients with benign prostatic obstruction(BPO). The effects of doxazosin, a selective α(1)-adrenoceptor antagonist, on urodynamic measurements were investigated in three double...

...C.R. Chapple; L. Baert; P. Thind; K. Höfner; G.S.S. Khoe; A. Spångberg Objectives: To compare the safety and tolerability of tamsulosin 0.4 mg once daily in younger (<65 years) and older (≥65 years) patients with lower urinary tract symptoms (LUTS) suggestive of benign prostatic obstruction (BPO...

... the economic perspective, the primary objective of the Triumph project is the assessment of the cost-effectiveness of treatment options for lower urinary tract symptoms (LUTS) suggestive of benign prostatic obstruction (BPO), formerly referred to as symptomtic benign prostatic hyperplasia (BPH), in medical...

... urinary tract symptoms Benign prostatic obstruction Medical therapy Surgery Primary care Secondary care Healthcare delivery Lower urinary tract symptoms (LUTS) suggestive of benign prostatic obstruction (BPO) is a common condition in the male population. Over the age of 40, the prevalence...

...Martin C. Michel; Mark Goepel The primary treatment goal in patients with lower urinary tract symptoms (LUTS) suggestive of benign prostatic obstruction (BPO) is symptom relief. However, it is also important to assess the effects of medical treatments on disease progression because this can lead...

... or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Lower urinary tract symptoms Benign prostatic obstruction Long-term effectiveness Triumph Electronic patient record Primary care GRPD IPCI THALES Lower urinary tract...

...Christopher R. Chapple Lower urinary tract symptoms (LUTS) suggestive of benign prostatic obstruction (BPO) are likely to become an increasing burden for health care budgets in the future due to the high prevalence of this condition in the elderly and the ageing of the population. Data on the cost...

... of benign prostatic obstruction with α 1 -adrenoceptor antagonists and other treatments. © 2000 S. Karger AG, Basel 2000 Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any...

... group) or approximately 3 years of tamsulosin treatment. Most patients received the 0.4-mg dose of tamsulosin (307 patients or 86%); in 48 patients (14%) the dose was increased to 0.8 mg. Lower urinary tract symptoms Benign prostatic obstruction α 1A -Adrenoceptor antagonist Tamsulosin, 3-year...

... aged over 80 years [ 1 ]. BPH is often associated with benign prostatic enlargement (BPE) and benign prostatic obstruction (BPO). BPO can result in lower urinary tract symptoms (LUTS) [ 2, 3 ]. LUTS can be brought about by simple mechanical obstruction in BPO, with the increased prostatic mass...

..., doxazosin, prazosin, tamsulosin and terazosin) have been recommended as appropriate treatment options for patients with lower urinary tract symptoms (LUTS) associated with benign prostatic obstruction (BPO), and their efficacy has been proven in several placebo-controlled trials. Finasteride reduces...

...Christian de Mey Alpha-adrenoceptor antagonists (α-blockers) are efficacious in treating lower urinary tract symptoms (LUTS) suggestive of benign prostatic obstruction (BPO), also termed symptomatic benign prostatic hyperplasia (BPH), causing bladder outlet obstruction (BOO). There is little...

...Pierre Teillac Benign prostatic hyperplasia (BPH) can cause benign prostatic enlargement with subsequent benign prostatic obstruction (BPO) and lower urinary tract symptoms (LUTS). A reduction in the size of the prostate has long been considered one of the most important treatment goals. However...